UK markets closed

Moberg Pharma AB (publ) (MOBS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
27.220.00 (0.00%)
At close: 08:34AM BST
Currency in SEK

Valuation measures4

Market cap (intra-day) 820.95M
Enterprise value 786.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.49k
Price/book (mrq)1.26
Enterprise value/revenue 959.44
Enterprise value/EBITDA -7.42

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 336.10%
S&P500 52-week change 326.24%
52-week high 334.74
52-week low 320.00
50-day moving average 331.28
200-day moving average 323.40

Share statistics

Avg vol (3-month) 3380
Avg vol (10-day) 3356
Shares outstanding 527.96M
Implied shares outstanding 6N/A
Float 824.1M
% held by insiders 130.41%
% held by institutions 15.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 404 Nov 2019
Last split factor 21:10
Last split date 324 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-962.93%

Management effectiveness

Return on assets (ttm)-3.08%
Return on equity (ttm)-3.98%

Income statement

Revenue (ttm)820k
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.44M
Net income avi to common (ttm)-22.56M
Diluted EPS (ttm)-1.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)38.63M
Total cash per share (mrq)1.38
Total debt (mrq)4.42M
Total debt/equity (mrq)0.73%
Current ratio (mrq)2.01
Book value per share (mrq)21.63

Cash flow statement

Operating cash flow (ttm)-31.39M
Levered free cash flow (ttm)-123.07M